Related Experiment Video
Updated: Jul 10, 2026

Isolation and Culture of Primary Mouse Keratinocytes from Neonatal and Adult Mouse Skin
Published on: July 14, 2017
TAK1 is a central mediator of NOD2 signaling in epidermal cells
Jae-Young Kim1, Emily Omori1, Kunihiro Matsumoto2
1Department of Environmental and Molecular Toxicology, North Carolina State University, Raleigh, North Carolina 27695.
Abstract:
Muramyl dipeptide (MDP) is a peptidoglycan moiety derived from commensal and pathogenic bacteria, and a ligand of its intracellular sensor NOD2. Mutations in NOD2 are highly associated with Crohn disease, which is characterized by dysregulated inflammation in the intestine. However, the mechanism linking abnormality of NOD2 signaling and inflammation has yet to be elucidated. Here we show that transforming growth factor beta-activated kinase 1 (TAK1) is an essential intermediate of NOD2 signaling. We found that TAK1 deletion completely abolished MDP-NOD2 signaling, activation of NF-kappaB and MAPKs, and subsequent induction of cytokines/chemokines in keratinocytes. NOD2 and its downstream effector RICK associated with and activated TAK1. TAK1 deficiency also abolished MDP-induced NOD2 expression. Because mice with epidermis-specific deletion of TAK1 develop severe inflammatory conditions, we propose that TAK1 and NOD2 signaling are important for maintaining normal homeostasis of the skin, and its ablation may impair the skin barrier function leading to inflammation.
Insights
Transforming growth factor beta-activated kinase 1 (TAK1) is crucial for Muramyl dipeptide (MDP)-NOD2 signaling. Its absence disrupts immune responses and skin barrier function, potentially leading to inflammation.
Area of Science:
- Immunology
- Molecular Biology
- Dermatology
Background:
- Muramyl dipeptide (MDP), a bacterial peptidoglycan component, signals through the intracellular sensor NOD2.
- NOD2 mutations are linked to Crohn disease, highlighting its role in intestinal inflammation.
- The precise mechanisms connecting NOD2 signaling dysfunction to inflammation remain unclear.
Purpose of the Study:
- To elucidate the role of transforming growth factor beta-activated kinase 1 (TAK1) as an intermediate in NOD2 signaling.
- To investigate the impact of TAK1 deficiency on NOD2-mediated immune responses.
- To explore the implications of TAK1 and NOD2 signaling in skin homeostasis and inflammation.
Main Methods:
- Investigated the interaction between NOD2, RICK, and TAK1.
- Assessed the effect of TAK1 deletion on MDP-NOD2 signaling pathways, including NF-kappaB and MAPK activation.
- Utilized keratinocytes and mice with epidermis-specific TAK1 deletion to study inflammatory responses.
Main Results:
- TAK1 was identified as an essential intermediate in MDP-NOD2 signaling.
- TAK1 deletion completely abolished MDP-NOD2 signaling, NF-kappaB and MAPK activation, and subsequent cytokine/chemokine induction.
- TAK1 deficiency also abrogated MDP-induced NOD2 expression and led to severe inflammatory conditions in mice with epidermis-specific TAK1 deletion.
Conclusions:
- TAK1 is a critical mediator of NOD2 signaling.
- TAK1 and NOD2 signaling are vital for maintaining skin homeostasis.
- Ablation of TAK1 and NOD2 signaling may compromise skin barrier function, contributing to inflammatory conditions.
Related Concept Videos
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
MAPK Signaling Cascades
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
